Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
64,305.31 +5,310.26 (+9.00%) CMC Crypto 200
1,359.39 +82.41 (+6.45%)
SoftBank Group Corp. (9984.T)
| Previous close | 7,789.00 |
| Open | 7,709.00 |
| Bid | 7,780.00 x 0 |
| Ask | 7,794.00 x 0 |
| Day's range | 7,677.00 - 7,803.00 |
| 52-week range | 4,854.00 - 9,386.00 |
| Volume | |
| Avg. volume | 10,600,713 |
| Market cap | 11.423T |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 44.00 (0.56%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | N/A |
- Reuters
WeWork reaches settlement with creditors, rebuffs Neumann bid
Shared office space provider WeWork announced on Monday a settlement with its junior creditors and a new cash infusion from its senior lenders, moving ahead with a bankruptcy deal that rejects a $650 million offer from co-founder and former owner Adam Neumann. During a hearing in Newark, New Jersey, U.S. Bankruptcy Judge John Sherwood signed off on the New York-based, SoftBank-backed company sending its restructuring plan to a creditor vote, putting it on track to exit bankruptcy by the end of May. The restructuring, now supported by all of WeWork's major creditors, would hand the company's equity to its senior lenders and cancel its $4 billion in debt.
- Reuters
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 million
Labcorp will acquire all of the bankrupt firm's assets on a going concern basis for $239 million in cash consideration and other non-cash consideration, the companies said in separate statements. In February, Invitae filed for voluntary Chapter 11 protection in a U.S. bankruptcy court and said that it intended to pursue a sale process. Invitae's estimated assets were in the $500 million - $1 billion range, while its liabilities were in the $1 billion - $10 billion range, according to the bankruptcy filing.
- Reuters
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln
Laboratory service provider Labcorp said on Wednesday it will acquire Softbank-backed Invitae Corp's assets auctioned through a voluntary bankruptcy protection process, a few months after the genetic test maker filed for bankruptcy. Labcorp will acquire all of the bankrupt firm's assets on a going concern basis for $239 million in cash consideration and other non-cash consideration, the companies said in separate statements. In February, Invitae filed for voluntary Chapter 11 protection in a U.S. bankruptcy court and said that it intended to pursue a sale process.
